The levels of dihydrocodeine found in impaired individuals and in fatalitie
s show a wide overlap in the ranges. Among other factors, the genetically c
ontrolled metabolism of dihydrocodeine should play an important role in dih
ydrocodeine toxicity.
For the first time, the most important metabolites of dihydrocodeine were i
nvestigated in femoral blood from three fatal cases by simultaneous determi
nation using HPLC and native fluorescence for detection. The amount of pare
nt drug always exceeded dihydrocodeine-glucuronide formation and dihydromor
phine concentrations ranged from 0.16-0.21 mg/L. The similar binding affini
ties of dihydromorphine and morphine to mu-opioid receptors suggest similar
pharmacological effects and adverse reactions. The determination of the ph
armacologically active metabolites should help to clarify the cause of deat
h in fatal cases especially if a relatively low concentration of the parent
drug is found.